OM1

Company profile

About OM1

OM1 is a pioneering healthcare AI and real-world evidence company that has developed the PhenOM foundation model, trained on over 1 billion patient-years of data. The company was founded to close the gap between what healthcare demands and what traditional evidence can deliver. OM1's technology enables digital patient phenotyping, medical event prediction, and outcomes forecasting to help healthcare leaders make data-driven decisions with confidence. The company's platform combines frontier AI technology with comprehensive real-world data covering 350M+ patients from EMR, claims, and specialty networks. OM1 holds 10+ patents in digital patient phenotyping, subtyping, outcomes measurement, and healthcare AI explainability. The company has demonstrated clinical impact through randomized controlled trials and has completed the largest AI-processed study with a successful regulatory submission for a new label indication. OM1 serves three primary markets: life sciences companies seeking to accelerate drug discovery and generate regulatory-ready evidence; healthcare providers looking to improve screening, patient finding, and quality scores; and payers aiming to identify high-risk members and measure ROI of care management programs. The company's solutions include patient finding and outcomes prediction, clinical registries and automated studies, clinical datasets and insights, and scientific consulting services. With experience in 300+ registries and observational studies, OM1 combines cross-functional expertise in data science, epidemiology, clinical research, and AI to transform how real-world evidence is generated and applied across the healthcare ecosystem.

Company description · OM1 official website